Meetings with Alaska Native Corporations, government officials and key stakeholders underscore positive momentum for the new ...

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 ...

Nanoform Finland Plc | Company Release | August 21, 2025 at 08:10:00 EEST First preliminary pivotal study results supportive for project Nanoenzalutamide to continue to progress towards the markets.

TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BWR Exploration Inc. (TSXV: BWR) a Toronto, Ontario based corporation with its registered address at 82 Richmond Street East, Toronto, Ontario ("BWR"), is ...

HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro ...

Helsinki, 21 August 2025 - Multitude Capital Oyj (the "Company"), a wholly-owned subsidiary of Multitude AG, announced today the publication of its Half-Year 2025 Report, encompassing the Interim ...

Strong second quarter for Kinepolis cinemas thanks to international blockbusters Regulated information 21 August 2025, 7.00 am CET After a weak start to the year due to a limited blockbuster offering, ...

August 21, 2025, Örnsköldsvik, Sweden. Clavister, a leader in European cybersecurity for mission-critical applications released its latest quarterly report for 2025. Order Intake grew by 52 %Net Sales ...

BEIJING, Aug. 20, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading gig economy platform focusing on local life services, today announced that it will change the ...

Revenue of $10,587,075 in Q2 2025, up 49% year-over-year; gross margin of 32% Adjusted EBITDA loss of $276,259, an 85% year-over-year improvement Current cash balance strengthened to approximately ...

Continued low activity in new construction but more stable renovationsector Kährs' order intake decreased by 14 per cent in the second quarter compared to the previous year, driven by a continued weak ...

Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson's disease, releases today the Company's 1H 2025 ...